B:b knob-hole interactions Polymerization of fibrin: direct observation and quantification of individual

[1]  L. Betts,et al.  The structure of fibrinogen fragment D with the 'A' knob peptide GPRVVE. , 2006 .

[2]  Sergiy Yakovlev,et al.  Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. , 2006, Biochemistry.

[3]  R. Doolittle,et al.  Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. , 2006, Biochemistry.

[4]  J. Weisel,et al.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. , 2005, Blood.

[5]  J. Weisel,et al.  Polymerization of fibrin: specificity, strength, and stability of knob-hole interactions studied at the single-molecule level. , 2005, Blood.

[6]  Rustem I. Litvinov,et al.  Multi-Step Fibrinogen Binding to the Integrin αIIbβ3 Detected Using Force Spectroscopy , 2005 .

[7]  M. Mosesson.  Fibrinogen and fibrin structure and functions , 2005, Journal of thrombosis and haemostasis : JTH.

[8]  F. Terasawa,et al.  Functional analysis of recombinant Bβ15C and Bβ15A fibrinogens demonstrates that Bβ15G residue plays important roles in FPB release and in lateral aggregation of protofibrils , 2005, Journal of thrombosis and haemostasis : JTH.

[9]  L. Betts,et al.  BβGlu397 and BβAsp398 but not BβAsp432 are required for B:b interactions , 2004 .

[10]  J. Weisel,et al.  Recombinant BβArg14His fibrinogen implies participation of N-terminus of Bβ chain in desA fibrin polymerization , 2003 .

[11]  L. Betts,et al.  2.8 A crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the "b" site disrupts its nearby calcium-binding site. , 2002, Biochemistry.

[12]  J. Weisel,et al.  Binding strength and activation state of single fibrinogen-integrin pairs on living cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Lord,et al.  Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation. , 2002, Biochemistry.

[14]  L. Medved,et al.  Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. , 2002, Biochemistry.

[15]  P. Bongrand,et al.  Measuring Receptor/Ligand Interaction at the Single-Bond Level: Experimental and Interpretative Issues , 2002, Annals of Biomedical Engineering.

[16]  R. Doolittle,et al.  Crystal Structure Studies on Fibrinogen and Fibrin , 2001, Annals of the New York Academy of Sciences.

[17]  J. Weisel,et al.  The Structure and Function of the αC Domains of Fibrinogen , 2001 .

[18]  S. Lord,et al.  The Formation of β Fibrin Requires a Functional a Site , 2001 .

[19]  I. Mochalkin,et al.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Doolittle,et al.  Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. , 1999, Biochemistry.

[21]  R. Doolittle,et al.  Crystal structure of fragment double-D from human fibrin with two different bound ligands. , 1998, Biochemistry.

[22]  S. Lord,et al.  Severely Impaired Polymerization of Recombinant Fibrinogen γ-364 Asp → His, the Substitution Discovered in a Heterozygous Individual* , 1997, The Journal of Biological Chemistry.

[23]  R. Doolittle,et al.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.

[24]  J. Weisel,et al.  The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. , 1997, Blood.

[25]  A. Ashkin,et al.  Optical trapping and manipulation of neutral particles using lasers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Davie,et al.  Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen , 1997 .

[27]  S. Lord,et al.  Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates. , 1996, Biochemistry.

[28]  T. Kamura,et al.  An Abnormal Fibrinogen Fukuoka II (Gly-Bβ 15 → Cys) Characterized by Defective Fibrin Lateral Association and Mixed Disulfide Formation * , 1995, The Journal of Biological Chemistry.

[29]  J. Weisel,et al.  Role of the alpha C domains of fibrin in clot formation. , 1994, Biochemistry.

[30]  J. Weisel,et al.  The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. , 1993, Journal of molecular biology.

[31]  D. Galanakis,et al.  Unusual A alpha 16Arg-->Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[32]  T. Ugarova,et al.  Interaction between complementary polymerization sites in the structural D and E domains of human fibrin. , 1992, The Journal of biological chemistry.

[33]  J. Weisel,et al.  Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. , 1992, Biophysical journal.

[34]  H. Hirata,et al.  A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine. , 1991, Blood.

[35]  B. Kudryk,et al.  Accessibility of epitopes on fibrin clots and fibrinogen gels. , 1991, Blood.

[36]  K. Preissner,et al.  Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization. , 1988, Biochimica et biophysica acta.

[37]  J. Weisel.  Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. , 1986, Biophysical journal.

[38]  Paul,et al.  Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. , 1985, The Journal of biological chemistry.

[39]  J. Shainoff,et al.  FIBRINOPEPTIDE B IN FIBRIN ASSEMBLY AND METABOLISM: PHYSIOLOGIC SIGNIFICANCE IN DELAYED RELEASE OF THE PEPTIDE * , 1983, Annals of the New York Academy of Sciences.

[40]  R. Doolittle,et al.  SYNTHETIC PEPTIDES MODELED ON FIBRIN POLYMERIZATION SITES , 1983, Annals of the New York Academy of Sciences.

[41]  A. Laudano,et al.  Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen. , 1981, Science.

[42]  A. Laudano,et al.  Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. , 1980, Biochemistry.

[43]  S. Olexa,et al.  Evidence for four different polymerization sites involved in human fibrin formation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Hermans,et al.  Assembly of fibrin. A light scattering study. , 1979, The Journal of biological chemistry.

[45]  J. Shainoff,et al.  Fibrinopeptide B and Aggregation of Fibrinogen , 1979, Thrombosis and Haemostasis.

[46]  B. Blombäck,et al.  A two-step fibrinogen–fibrin transition in blood coagulation , 1978, Nature.

[47]  A. Laudano,et al.  Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Hermans,et al.  Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod. , 1977, The American journal of physiology.

[49]  J. Soria,et al.  Fibrinogen Troyes - Fibrinogen Metz , 1972, Thrombosis and Haemostasis.

[50]  J. Shainoff,et al.  Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B. , 1970, The Journal of laboratory and clinical medicine.

[51]  J. Weisel.  Fibrinogen and fibrin. , 2005, Advances in protein chemistry.

[52]  A. Ashkin,et al.  Forces of a single-beam gradient laser trap on a dielectric sphere in the ray optics regime. , 1992, Biophysical journal.

[53]  J. Soria,et al.  Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). , 1987, Blood.

[54]  R. Doolittle.  Fibrinogen and fibrin. , 1984, Annual review of biochemistry.

[55]  B. Kudryk,et al.  Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. , 1984, Molecular immunology.

[56]  A. Henschen,et al.  Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[57]  J. Soria,et al.  Anomalie de structure du fibrinogène “Metz”, localisée sur la chaîne α (A) de la molécule , 1972 .

[58]  T. Laurent,et al.  On the Significance of the Release of Two Different Peptides from Fibrinogen During Clotting. , 1958 .